RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ASND
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Wednesday for Ascendis Pharma A/S
(Updated on May 01, 2024)

Hold candidate since Apr 29, 2024 Gain 0.61% PDF

The Ascendis Pharma A/S stock price gained 1.86% on the last trading day (Wednesday, 1st May 2024), rising from $138.44 to $141.01. During the last trading day the stock fluctuated 4.82% from a day low at $136.00 to a day high of $142.55. The price has fallen in 6 of the last 10 days and is down by -0.82% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 167 thousand more shares were traded than the day before. In total, 407 thousand shares were bought and sold for approximately $57.38 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.46% during the next 3 months and, with a 90% probability hold a price between $130.93 and $149.74 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ASND Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has risen 3.76%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ascendis Pharma A/S stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $145.84. On a fall, the stock will find some support from the short-term average at $140.06. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Ascendis Pharma A/S stock

Ascendis Pharma A/S finds support from accumulated volume at $139.77 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $6.55 between high and low, or 4.82%. For the last week, the stock has had daily average volatility of 4.10%.

Our recommended stop-loss: $133.93 (-5.02%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (ASND) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Ascendis Pharma A/S to open at $139.85, and during the day (based on 14 day Average True Range), to move between $135.68 and $146.34, which gives a possible trading interval of +/-$5.33 (+/-3.78%) up or down from last closing price. If Ascendis Pharma A/S takes out the full calculated possible swing range there will be an estimated 7.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $139.77 (0.88%) than the resistance at $143.35 (1.66%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Ascendis Pharma A/S will release earnings AMC on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.57. We will update the financials statements for Ascendis Pharma A/S, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.74% in the first trading day after earnings release.

Is Ascendis Pharma A/S stock A Buy?

Ascendis Pharma A/S holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.233 Hold/Accumulate Unchanged

Predicted Opening Price for Ascendis Pharma A/S of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$139.85 ( 0.82%) $141.01

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ASND

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 146.40 3.82 %
R2 143.90 2.05 %
R1 142.36 0.95 %
Current price: 141.01
Support S1 137.35 -2.59 %
S2 135.81 -3.69 %
S3 133.30 -5.47 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 147.76 4.79 %
R2 145.37 3.09 %
R1 143.35 1.66 %
Current price 141.01
Support S1 139.77 -0.88%
S2 139.29 -1.22%
S3 139.25 -1.25%

FAQ

What is the symbol for Ascendis Pharma A/S Stock and on which exchange is it traded?
The symbol for Ascendis Pharma A/S is ASND and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ascendis Pharma A/S Stock?
Ascendis Pharma A/S holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Ascendis Pharma A/S Stock?
Ascendis Pharma A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ascendis Pharma A/S Stock.

What's the current price of Ascendis Pharma A/S Stock?
As of the end of day on the May 01, 2024, the price of an Ascendis Pharma A/S (ASND) share was $141.01.

What is the 52-week high and low for Ascendis Pharma A/S Stock?
The 52-week high for Ascendis Pharma A/S Stock is $161.00 and the 52-week low is $83.75.

What is the market capitalization of Ascendis Pharma A/S Stock?
As of the May 01, 2024, the market capitalization of Ascendis Pharma A/S is 7.935B.

When is the next earnings date for Ascendis Pharma A/S?
The upcoming earnings date for Ascendis Pharma A/S is May 02, 2024.
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT